Director Gregory Bailey Acquires 15,000 Shares of Biohaven Ltd (BHVN)

Down -24.55% in 4 Weeks, Here's Why Biohaven Ltd. (BHVN) Looks Ripe for a Turnaround

Down -32.76% in 4 Weeks, Here's Why Biohaven Ltd. (BHVN) Looks Ripe for a Turnaround

Biohaven Reports First Quarter 2024 Financial Results and Recent Business Developments

Independent Director of Biohaven John Childs Buys 3.2% More Shares

3 Biotech Stocks to Buy on the Dip: April 2024

Director Gregory Bailey Acquires 25,503 Shares of Biohaven Ltd (BHVN)

Director Gregory Bailey Acquires 48,780 Shares of Biohaven Ltd (BHVN)

Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

Biohaven Announces Pricing of $230 Million Public Offering of Common Shares

Biohaven Announces Proposed Public Offering of Common Shares

Biohaven Showcases Innovative Neuroscience Portfolio with 20 Presentations at the 2024 American Academy of Neurology (AAN) Annual Meeting and Provides Other Business Updates